National and Kapodistrian University of Athens
Μελέτη της ενεργοποίησης των μαστοκυττάρων από νευροπεπτίδια και παθογόνους παράγοντες και η συμβολή τους στην παθογένεια του αυτισμού
Abstract
dc:descriptionAutism spectrum disorders (ASD) are neurodevelopmental disorders characterized byvarying degrees of dysfunctional communication and social interactions, repetitive andstereotypic behaviors, as well as learning and sensory deficits. Despite the impressiverise in the prevalence of autism during the last two decades, there are few if any cluesfor its pathogenesis or early detection or treatment. Increasing evidence indicates highbrain expression of pro-inflammatory cytokines and the presence of circulatingantibodies against brain proteins. A number of papers, mostly based on parentalreporting on their children's health problems, suggest that ASD children may presentwith “allergic-like” problems in the absence of elevated serum IgE and chronic urticaria.These findings suggest non-allergic mast cell activation, probably in response toenvironmental and stress triggers that could contribute to inflammation. We speculatethat mast cell activation leads to disruption of the gut-blood-brain barriers, thuscontributing to brain inflammation and autism pathogenesis. The primary aim of this doctorate thesis was to elucidate mechanisms of mast cellactivation that may be implicated in ASD. For this purpose we used molecular methods,including ELISA and Luminex to measure levels of neuropeptides and cytokines thatare released by and/or activate mast cells in the serum of children with autism andcontrols (typically developing children). We also used a human mast cell line to test theeffects of variable triggers on mast cells. Gene expression of target molecules wasmeasured by means of PCR. Our results indicate that neurotensin (NT), a neuropeptidepresent in the brain and the gastrointestinal tract, is increased in the serum of childrenwith autism compared to typically developing controls. A number of studies report mitochondrial dysfunction in autism, leading to alteredenergy metabolism, at least in a subgroup of patients. We hypothesized thatmitochondrial components are released extracellularly and may account for an“autoimmune” response in those individuals. To test this hypothesis we measured levelsof mitochondrial antibodies and mitochondrial DNA in serum of children with autism andcontrols. We found that serum from autistic children contains significantly higheramounts of mitochondrial DNA (mtCytB, mt7S) and antibodies (AMA-M2) compared tocontrols. We further hypothesized that NT may be able to trigger release ofmitochondrial components extracellularly from human mast cells. Stimulation of LAD2cells with NT resulted indeed in significant release of mitochondrial DNA in the supernatant fluid. Mitochondrial components were found to augment vascularendothelial growth factor (VEGF) release from human mast cells, an effect inhibited bythe flavonoid luteolin. Increased anxiety seems to be present in at least a subgroup of patients with ASDs.Corticotropin-releasing hormone (CRH) secreted under stress may worsen ASDsymptomatology through disruption of the blood-brain-barrier and/or accentuation of“allergic-like” symptoms. We showed that CRH not only augments release of VEGF, butcan also induce FcεRI expression in human cord blood-derived mast cells. Another aim of this study was to investigate the prevalence of allergic manifestationsand gastrointestinal symptoms in children with ASD. We performed a population-wideobservational study using the nationwide U.S.-based Autism Consortium Database toextract data on autistic children, and used population-derived data from two U.S.national studies for comparisons to the general pediatric population. We found that 46%of the study participants reported having allergies, the majority being seasonal (24%),followed by food allergies (17%). Prevalence estimates for food allergy were noticeablyhigher compared to 5.2% in the general pediatric population. In addition, 49% of thestudy participants reported gastrointestinal symptoms, consistent with estimatesbetween 9-70% in the literature. Presence of allergic or gastrointestinal symptoms didnot correlate with autism severity. “Allergic-like” symptoms and gastrointestinal problems are common in ASD, possiblyrelated to increased mast cell responsiveness, which may define at least a subgroup ofASD patients, who could benefit from inhibition of mast cell activation.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Angelidou, Asimenia
- Αγγελίδου, Ασημένια
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39036